Science&Humans provides personalized, data-driven hormone healthcare aimed at closing the hormone care gap for both men and women. The company offers digital hormone care services and emphasizes tailored treatment across life stages where hormone health is fragmented. Leadership, including co-founder Hira S., has been public about the market need in media appearances such as on BNN Bloomberg. Science&Humans says demand is accelerating, particularly among younger demographics, and that employers and insurers are increasingly engaged due to workforce impacts. Following a $10 million Series A, the company is focused on scaling access and building its next-generation digital hormone healthcare offerings.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2026